Oragenics Inc (AMEX:OGEN) currently has a daily average trading volume of 591.94K but it saw 3207219 shares traded in last market. With a market cap of 3.21M USD, the company’s current market price of $0.58 came falling about -46.20 while comparing to the previous closing price of $1.07. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.74 and as low as $0.86. In the recent trading on the day, stock has struck highest price mark of $0.5401 while lowest mark touched by it was $0.592.
Taking a look at 20-day trading activity of Oragenics Inc (OGEN) gives us an average price of $1.2189, while its current price level is -92.56% below from 52-week high level whereas it is -33.14% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1138 while that of 200 days or SMA-200 reads an average of $2.4020. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.32% during that period while stretching the period over a month that increases to 23.94%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 36.91 which implies that the stock is in neutral territory.
Over the week, OGEN’s stock price is moving -54.67% down while it is -35.78% when we observe its performance for the past one month. Year-to-date it is -89.77% down and over the past year, the stock is showing a downside performance of -83.41%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1.8 beat the consensus estimate of -2.4 for the same. The company is expected to be releasing its next quarterly report on 2023-May-12, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Oragenics Inc’s total number of outstanding shares is 5.58M with 18.65% of that held by the insiders while 7.08% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -1471.37% and return on equity (ROE) at -454.72%. Stock’s beta reads 0.51. Stock has a price to sale or P/S ratio amounts to 321.24. Its return on asset (ROA) is -349.31% on average.
